Microbiologist Norman Dondero dies at age 95

Posted on by

Jul. 17, 2013

Norman C. Dondero, Ph.D. 52, Cornell professor emeritus of microbiology who taught and pursued research in the field of microbiology of water, water pollution and biological waste treatment, died July 10 at Kendal at Ithaca. He was 95.

A scientist, artist and naturalist, Dondero grew up in Massachusetts, earning his B.S. (1941) at the University of Massachusetts; he earned his M.S. (1943) at the University of Connecticut and Ph.D. (1952) at Cornell.

From 1943 to 1946, he served in the U.S. Army. From 1954 to 1966, he taught at Rutgers University and joined the Cornell faculty in 1966; he retired from Cornell in 1984.

Dondero was predeceased by his wife, Wilma Mehlenbacher Hyde; he is survived by a son and extended family members.

At his request there will be no calling hours, and a private family graveside service is planned. Donations in his memory can be made to the Finger Lakes Land Trust, the Nature Conservancy or any environmental conservation group.

You can view his memorial or express condolences to the family online at http://www.Royce-Chedzoy.com.

Continued here:
Microbiologist Norman Dondero dies at age 95

Stem Cell Therapy Treatment for Friedreichs Ataxia by Dr Alok Sharma, Mumbai, India. – Video

Posted on by


Stem Cell Therapy Treatment for Friedreichs Ataxia by Dr Alok Sharma, Mumbai, India.
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Friedreichs Ataxia by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Speech h...

By: Neurogen Brain and Spine Institute

Read more here:
Stem Cell Therapy Treatment for Friedreichs Ataxia by Dr Alok Sharma, Mumbai, India. - Video

Stem Cell Therapy Market in Asia-Pacific to 2018

Posted on by

DUBLIN, July 18, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/qc7zk2/stem_cell_therapy) has announced the addition of the "Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity

Stem Cell Research in Asia-Pacific a Growth Engine for Region's Scientific Ambitions

The stem cell therapy market in Asia-Pacific is poised to offer significant contributions in the future, thanks to renewed interest by the respective governments of India, China, Japan, South Korea and Singapore to provide cures for a range of diseases, states a new report by healthcare experts GBI Research.

Stem cells are unique body cells that possess the ability to divide and differentiate into diverse cell types, and can be used to produce more stem cells. The use of adult stem cells has been successfully employed to treat bone and blood related disorders such as leukemia, through bone marrow transplants. Stem cell therapy is used to repair and regenerate the damaged tissue, though the actual mechanism of action is largely unknown.

The growth in the stem cell therapy market will not only provide treatment options but will also contribute significantly to the countries' Gross Domestic Product (GDP), with the President of South Korea only last year referring to stem cell research as a new growth engine for the nation's economy. In order to support the stem cell industry, regulatory guidelines in Asia-Pacific countries allow stem cell research, and this has led to its commercialization. India and South Korea are the leaders in the commercialization of stem cell therapy, with approved products for Acute Myocardial Infarction (AMI), osteoarthritis and anal fistula in Crohn's disease, amongst others. The countries allow the use of human embryonic stem cells and provide adequate funding support for the research.

Stem cell therapy is an emerging field, and a large amount of research is currently being carried out by institutions such as hospitals, universities and medical colleges. According to GBI Research's analysis of the stem cell therapy research in Asia-Pacific, 63% of pipeline molecules were being researched by academia. The emergence of institutional research has boosted stem cell discoveries, as companies can be put off conducting research due to uncertain therapeutic outcomes. China and Japan witness only a negligible industry presence in stem cell research, as academic institutions dominate - however in contrast, India has the presence of both industry and academia. The major institutions engaged in stem cell research in India are LV Prasad Eye Institute (LYPEI) for Limbal Stem Cell Technology (LSCT), and the Post Graduate Institute of Medical Education and Research (PGIMER) for stem cell therapy for type 2 diabetes mellitus.

The market is poised for significant growth in the future, due to the anticipated launch of JCR Pharmaceuticals' JR-031 in Japan in 2014, and FCB Pharmicell's Cerecellgram (CCG) in South Korea in 2015. GBI Research therefore predicts that the stem cell therapy market will grow in value from $545m in 2012 to $972m in 2018, at a Compound Annual Growth Rate (CAGR) of 10%.

Read the original:
Stem Cell Therapy Market in Asia-Pacific to 2018

Connect, Collaborate, Solve with Thermo Scientific Pharmaceutical Microbiology Solutions – Video

Posted on by


Connect, Collaborate, Solve with Thermo Scientific Pharmaceutical Microbiology Solutions
Thermo Scientific Pharmaceutical Microbiology Solutions include a full range of quality Thermo Scientific Oxoid and Remel products for your pharmaceutical mi...

By: thermoscientific2

Continue reading here:
Connect, Collaborate, Solve with Thermo Scientific Pharmaceutical Microbiology Solutions - Video

American Academy of Microbiology publishes West Nile virus report

Posted on by

Public release date: 18-Jul-2013 [ | E-mail | Share ]

Contact: Garth Hogan ghogan@asmusa.org 202-942-9389 American Society for Microbiology

Where does the virus come from? How is it spread? Can we predict when and where outbreaks will occur? What factors determine how sick a person will become if they are infected with West Nile virus?

To help answer the many questions people have about this multi-faceted virus, the American Academy of Microbiology has issued a new report entitled FAQ: West Nile Virus. The Academy convened twenty-two of the world's leading experts on West Nile virus in March, 2013 to consider and answer some of the most frequently asked questions about West Nile virus. The resultant report provides non-technical, science-based answers to questions that people may have about the virus.

"West Nile virus is the most significant exotic mosquito-borne disease that has come to the contiguous United States in the last century," according to Dr. Lyle Peterson, Director of the Division of Vector-borne Infectious Diseases at the Centers for Disease Control and Prevention. "Outbreaks have proven extremely difficult to predict and control and have been associated with considerable morbidity. The large outbreak in 2012, which caught many by surprise, indicates that West Nile virus will remain a formidable public health challenge for years to come."

Indeed, 2012 marked the largest outbreak of West Nile virus in the United States since 2003, and already in 2013, mosquitos infected with this potentially deadly virus have been detected in 21 states with human cases of West Nile infection reported in California, Mississippi, South Dakota, Tennessee, and Texas. Where does the virus come from? How is it spread? Can we predict when and where outbreaks will occur? What factors determine how sick a person will become if they are infected with West Nile virus?

"We desperately need to better understand the ecology, epidemiology, and pathogenesis of this virus in order to develop effective preventive measures and antiviral therapy," says Dr. Ken Tyler, University of Colorado in Denver.

To help answer the many questions people have about this multi-faceted virus, the American Academy of Microbiology has issued a new report entitled FAQ: West Nile Virus. The Academy convened twenty-two of the world's leading experts on West Nile virus in March, 2013 to consider and answer some of the most frequently asked questions about West Nile virus. The resultant report provides non-technical, science-based answers to questions that people may have about the virus.

Some of the questions the report considers include:

FAQ: West Nile virus is the latest offering in a series of reports designed to provide a rapid response to emerging issues or to highlight the role of microbes in daily life. Previous FAQ reports have covered topics like the role of microorganisms in cleaning up oil spills and the central role of yeast in the production of beer.

Continue reading here:
American Academy of Microbiology publishes West Nile virus report

Seminar on Health and Beauty hinged on Stem Cell Technology

Posted on by

19th July, 2013

World-renowned anti-aging cellular therapy brand MFIII of Switzerland will be conducting a seminar on stem cell technology at a leading hotel in Kota Kinabalu this Sunday.

Themed Maintaining Health and Beauty, it will feature a talk by MFIII Medical Consultant Dr. Mikhail Teppone, focusing on Swiss cellular therapy, a natural rejuvenation method that has proven effective against aging and chronic diseases, said Andy Lim, managing director of Color Spectrum Sdn Bhd which is hosting the half-day event. The company is the sole authorized dealer of MFIII products in Sabah.

Andy explained that cellular therapy is an antecedent of modern stem cell biology. It essentially represents the administration of cellular materials from foetal tissues into the human body for therapeutic purpose, a method scientifically proven to be effective in the delay of human aging.

MFIII pioneered the development of the first placenta extract oral health supplement with potent anti-aging capabilities. This product continues to be a global best-seller and premium product for the company.

Subsequently, MFIII has come out with wholesome anti-aging skincare products and products that reinforce the bodys immune defence system.

MFIII products are distributed worldwide by Lab Dom (Suisse) Inc., a world leader in the generative medicine industry and cellular therapy field.

Dr. Teppone is also a qualified neurologist and accomplished acupuncturist and is a member of the Russian Medical Academy as well as the Canadian Sociality of Chinese Medicine and Acupuncture.

He has penned numerous medical journals covering such diverse topics as Microwaves in Medicine, Medical Acupuncture and on Medical Physics and Biomedical Engineering.

Attendance of the seminar is vide ticket priced at RM100 per head, bundled with high tea, door gifts, product discount and lucky draw. For registration, call Color Spectrum at 088-702273.

Read the original post:
Seminar on Health and Beauty hinged on Stem Cell Technology

Photo Release: VitallifeExpert Shares Knowledge and Insight at International Anti-Aging Conference in Japan

Posted on by

Food and Healthcare Press Releases Friday July 19, 2013

Bangkok--19 Jul--Grayling (Thailand)

One of Thailand's leading anti-aging experts, Asst Prof Pansak Sugkraroek (far right), Medical Director,Vitallife, recently attended the third annual International Conference on Anti-Aging Medicine in Yokohama, Japan. As a guest lecturer,Asst Prof Pansak shared his knowledge and expertise on the topic, "Caloric Restriction with Optimum Nutrition: Scientific Interventions for Anti-Aging."

Attended by international specialists, the Anti-Aging Medicine conference was organized by the Japanese Society of Anti-Aging Medicine (JAAM), one of the world's largest academic groups studying the advancement of anti-aging medicine.

AsstProf Pansak was joined on stage by, from left: Prof Shigeo Horie, President Japan Association of Anti-aging Medicine, Prof Marcia C Haigis, Harvard Medical School USA, Prof Young JeonSurh, Seoul National University Korea, Prof Masao Kaneki, Harvard Medical School USA and Asst Prof Pansak Sugkraroek.

Vitallife is the Preventive, Regenerative, and Integrative Wellness Centre of Bumrungrad International Hospital

For more information please contact

Pimpailin Teeraleela or Pitchapa Ratchanan

Grayling (Thailand) Tel02-635-7151-2Fax02-635-7155

E-mail: pimpailin@grayling.com andpitchapa@grayling.com

Read the original here:
Photo Release: VitallifeExpert Shares Knowledge and Insight at International Anti-Aging Conference in Japan

Research and Scholarship

Posted on by

UCR Celebrates First Undergraduate Microbiology Grad

Cristian Carrera

The undergraduate microbiology major, which was launched in fall 2011, has its first graduate: Cristian Carrera, who received his bachelor of arts degree last June. Carrera, who grew up in Chino, is interested in pursuing a career in microbiology.

I want to learn more about bacteria, viruses and other microscopic organisms, he said. I am also interested in immunology.

The first person in his family to graduate from college, Carrera wasnt expecting to make UCR history.

I am proud to be the first graduate in the microbiology major, he said. I didnt know I had this honor until only very recently.

Carrera plans to become a professor in microbiology. He is interested, too, in teaching at a high school for a few years.

I used to run cross-country and play soccer, he said. Teaching at a high school will give me a chance to coach.

The steering committee for the microbiology major James Borneman, Katherine Borkovich and Marylynn Yates presented Carrera with a plaque to commemorate the milestone the microbiology major has reached.

I had the pleasure of having Cristian as one of my students in my new research-based course Experimental Microbiology during the Spring 2013 quarter, Borkovich said. Cristian was an excellent student and will be a great representative for both UCR and the new microbiology major out in the larger community. I wish him well as he embarks on the next stage of his career.

The rest is here:
Research and Scholarship

Stem Cell Therapy Treatment for Autism by Dr Alok Sharma, Mumbai, India. Part 2 – Video

Posted on by


Stem Cell Therapy Treatment for Autism by Dr Alok Sharma, Mumbai, India. Part 2
Improvement seen in just 7 months after Stem Cell Therapy Treatment for Autism by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Emotional respons...

By: Neurogen Brain and Spine Institute

Read the original here:
Stem Cell Therapy Treatment for Autism by Dr Alok Sharma, Mumbai, India. Part 2 - Video

Stem Cell Therapy Treatment for Idiopathic Polymyositis by Dr Alok Sharma, Mumbai, India. – Video

Posted on by


Stem Cell Therapy Treatment for Idiopathic Polymyositis by Dr Alok Sharma, Mumbai, India.
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Idiopathic Polymyositis by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Fle...

By: Neurogen Brain and Spine Institute

Go here to see the original:
Stem Cell Therapy Treatment for Idiopathic Polymyositis by Dr Alok Sharma, Mumbai, India. - Video